HK55195A - Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents. - Google Patents

Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents.

Info

Publication number
HK55195A
HK55195A HK55195A HK55195A HK55195A HK 55195 A HK55195 A HK 55195A HK 55195 A HK55195 A HK 55195A HK 55195 A HK55195 A HK 55195A HK 55195 A HK55195 A HK 55195A
Authority
HK
Hong Kong
Prior art keywords
magnetic resonance
nuclear magnetic
contrast agents
resonance imagery
dipyridoxyl
Prior art date
Application number
HK55195A
Other languages
English (en)
Inventor
Scott M Rocklage
Steven C Quay
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of HK55195A publication Critical patent/HK55195A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Signal Processing (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK55195A 1987-05-08 1995-04-11 Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents. HK55195A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/047,614 US4933456A (en) 1987-05-08 1987-05-08 Dipyridoxyl phosphate NMRI contrast agents

Publications (1)

Publication Number Publication Date
HK55195A true HK55195A (en) 1995-04-21

Family

ID=21949962

Family Applications (1)

Application Number Title Priority Date Filing Date
HK55195A HK55195A (en) 1987-05-08 1995-04-11 Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents.

Country Status (20)

Country Link
US (1) US4933456A (nl)
EP (1) EP0290047B1 (nl)
JP (1) JP2512524B2 (nl)
AR (1) AR246956A1 (nl)
AT (1) ATE118010T1 (nl)
AU (1) AU613363B2 (nl)
BR (1) BR1100623A (nl)
CA (1) CA1322003C (nl)
DE (2) DE19775088I2 (nl)
DK (1) DK173849B1 (nl)
ES (1) ES2066768T3 (nl)
FI (1) FI88164C (nl)
GR (1) GR3015884T3 (nl)
HK (1) HK55195A (nl)
IE (1) IE66368B1 (nl)
IL (1) IL86298A (nl)
NL (1) NL970040I2 (nl)
NO (2) NO177462C (nl)
NZ (1) NZ224537A (nl)
SG (1) SG30569G (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4994259A (en) * 1987-05-08 1991-02-19 Salutar, Inc. Improvement in the method of NMR imaging employing a manganese II chelates of N,N'-bis[pyridoxal-alkylene (or cycloalkylene) (or arylene)]-N,N'-diacetic acid derivatives
US4827426A (en) * 1987-05-18 1989-05-02 The Coca-Cola Company Data acquisition and processing system for post-mix beverage dispensers
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
WO1991012822A1 (de) * 1990-03-02 1991-09-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Zubereitungen für die mr-diagnostik
DE4026103A1 (de) * 1990-08-17 1992-02-20 Byk Gulden Lomberg Chem Fab Neue verwendung von komplexsalzen
AU8325491A (en) * 1990-08-15 1992-03-17 Byk Gulden Lomberg Chemische Fabrik Gmbh New use of complex salts
WO1992011840A1 (de) * 1991-01-07 1992-07-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Kontrastmittel für die mr-diagnostik
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
AU660033B2 (en) * 1991-05-23 1995-06-08 Imarx Pharmaceutical Corp. Liposoluble compounds for magnetic resonance imaging
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
TW319763B (nl) 1995-02-01 1997-11-11 Epix Medical Inc
SG81898A1 (en) * 1995-08-11 2001-07-24 Sumitomo Chemical Co Olefin polymerization catalyst component, olefin polymerization catalyst and process for producing olefin polymer
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
DE69838873T2 (de) * 1997-07-01 2008-12-04 Ge Healthcare As Diagnostisches verfahren zum nachweis von myokard-ischämie
EP1060174B1 (en) * 1997-12-23 2004-09-22 Amersham Health AS Nitric oxide releasing chelating agents and their therapeutic use
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
KR102086022B1 (ko) * 2012-01-05 2020-03-06 플레드파르마 에이비 칼망가포디피르, 신규 화학 물질 및 기타 혼합 금속 착물, 제조방법, 조성물 및 치료방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632637A (en) * 1968-02-13 1972-01-04 Arthur E Martell Hydroxyaryl-containing aminocarboxylic chelating agents
AU485693B2 (en) * 1973-08-24 1976-02-05 The Council Ofthe Institute Of Medical And Veterinary Science, Andthe Universityof Adelaide Gariti Cancer Foundation New radiopharmaceuticals for cholescintigraphy
JPS5569517A (en) * 1978-11-20 1980-05-26 Nippon Mejifuijitsukusu Kk Labelling preparation for labelling of erythrocytes with radio-active technetium
JPS5791927A (en) * 1980-11-27 1982-06-08 Nippon Mejifuijitsukusu Kk Technetium-99m labelled diagnosticum
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US4842845A (en) * 1987-05-08 1989-06-27 Salutar, Inc. Radioactive metal chelates for dipyridoxyl phosphate
US4935518A (en) 1987-05-08 1990-06-19 Salutar, Inc. Manganese(II), chelate contrast agents derived from N,N'-bis-(pyridoxal ethylene diamine-N,N')-diacetic acid and derivatives thereof

Also Published As

Publication number Publication date
US4933456A (en) 1990-06-12
DE3852906D1 (de) 1995-03-16
IL86298A (en) 1992-11-15
NO882004L (no) 1988-11-09
IE881366L (en) 1988-11-08
IL86298A0 (en) 1988-11-15
ES2066768T3 (es) 1995-03-16
DE19775088I2 (de) 2001-05-23
DK173849B1 (da) 2001-12-27
FI882125A (fi) 1988-11-09
NO1998004I1 (no) 1998-01-19
EP0290047A3 (en) 1990-04-25
FI88164C (fi) 1993-04-13
NZ224537A (en) 1991-06-25
IE66368B1 (en) 1995-12-27
NO177462B (no) 1995-06-12
CA1322003C (en) 1993-09-07
DK251688A (da) 1988-11-09
SG30569G (en) 1995-09-18
EP0290047A2 (en) 1988-11-09
EP0290047B1 (en) 1995-02-01
FI88164B (fi) 1992-12-31
AU613363B2 (en) 1991-08-01
FI882125A0 (fi) 1988-05-06
DK251688D0 (da) 1988-05-06
AU1568088A (en) 1988-11-10
JP2512524B2 (ja) 1996-07-03
DE3852906T2 (de) 1995-06-22
AR246956A1 (es) 1994-10-31
NL970040I2 (nl) 1998-06-02
GR3015884T3 (en) 1995-07-31
JPS63280087A (ja) 1988-11-17
NO882004D0 (no) 1988-05-06
BR1100623A (pt) 1999-12-07
NL970040I1 (nl) 1998-02-02
ATE118010T1 (de) 1995-02-15
NO177462C (no) 1995-09-20

Similar Documents

Publication Publication Date Title
HK55195A (en) Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents.
EP0240319A3 (en) Magnetic resonance imaging system
EP0412824A3 (en) Magnetic resonance imaging system
EP0412695A3 (en) Magnetic resonance imaging
GB2157832B (en) Nuclear magnetic resonance imaging
DE3569614D1 (en) Magnetic resonance imaging system
GB8528357D0 (en) Nuclear magnetic resonance imaging
GB8813425D0 (en) Magnetic resonance imaging
DE3855944D1 (de) Kernresonanzabbildungssystem
EP0204320A3 (en) Magnetic resonance imaging method
IL76398A (en) Magnetic resonance imaging
GB2234594B (en) Nuclear magnetic resonance imaging methods
GB2201794B (en) Magnetic resonance imaging system
EP0335981A4 (en) MAGNETIC RESONANCE IMAGING SYSTEM.
DE3574055D1 (en) Nuclear magnetic resonance imaging
EP0306960A3 (en) Magnetic card
EP0139102A3 (en) Nuclear magnetic resonance imaging system
GB2162641B (en) Nuclear magnetic resonance
GB8521791D0 (en) Nuclear magnetic resonance imaging
GB8611963D0 (en) Nuclear magnetic resonance
GB2234595B (en) Nuclear magnetic resonance imaging methods
GB2182451B (en) Nuclear magnetic resonance imaging
GB8415530D0 (en) Nuclear magnetic resonance imaging
GB8716606D0 (en) Magnet coil
GB8622579D0 (en) Nuclear magnetic resonance imaging methods

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PF Patent in force
PE Patent expired

Effective date: 20080505